PURPOSE: Health Plans are uniquely positioned to deliver outreach to members. We explored whether telephone outreach, delivered by Medicaid managed care organization (MMCO) staff, could increase colorectal cancer (CRC) screening among publicly insured urban women, potentially reducing disparities. METHODS: We conducted an 18-month randomized clinical trial in 3 MMCOs in New York City in 2008-2010, randomizing 2,240 MMCO-insured women, aged 50 to 63 years, who received care at a participating practice and were overdue for CRC screening. MMCO outreach staff provided cancer screening telephone support, educating patients and helping overcome barriers. The primary outcome was the number of women screened for CRC during the 18-month intervention, assessed using claims. RESULTS:MMCO staff reached 60% of women in the intervention arm by telephone. Although significantly more women in the intervention (36.7%) than in the usual care (30.6%) arm received CRC screening (odds ratio [OR] = 1.32; 95% CI, 1.08-1.62), increases varied from 1.1% to 13.7% across the participating MMCOs, and the overall increase was driven by increases at 1 MMCO. In an as-treated comparison, 41.8% of women in the intervention arm who were reached by telephone received CRC screening compared with 26.8% of women in the usual care arm who were not contacted during the study (OR = 1.84; 95% CI, 1.38, 2.44); 7 women needed to be reached by telephone for 1 to become screened. CONCLUSIONS: The telephone outreach intervention delivered by MMCO staff increased CRC screening by 6% more than usual care among randomized women, and by 15.1% more than usual care among previously overdue women reached by the intervention. Our research-based intervention was successfully translated to the health plan arena, with variable effects in the participating MMCOs.
RCT Entities:
PURPOSE: Health Plans are uniquely positioned to deliver outreach to members. We explored whether telephone outreach, delivered by Medicaid managed care organization (MMCO) staff, could increase colorectal cancer (CRC) screening among publicly insured urban women, potentially reducing disparities. METHODS: We conducted an 18-month randomized clinical trial in 3 MMCOs in New York City in 2008-2010, randomizing 2,240 MMCO-insured women, aged 50 to 63 years, who received care at a participating practice and were overdue for CRC screening. MMCO outreach staff provided cancer screening telephone support, educating patients and helping overcome barriers. The primary outcome was the number of women screened for CRC during the 18-month intervention, assessed using claims. RESULTS: MMCO staff reached 60% of women in the intervention arm by telephone. Although significantly more women in the intervention (36.7%) than in the usual care (30.6%) arm received CRC screening (odds ratio [OR] = 1.32; 95% CI, 1.08-1.62), increases varied from 1.1% to 13.7% across the participating MMCOs, and the overall increase was driven by increases at 1 MMCO. In an as-treated comparison, 41.8% of women in the intervention arm who were reached by telephone received CRC screening compared with 26.8% of women in the usual care arm who were not contacted during the study (OR = 1.84; 95% CI, 1.38, 2.44); 7 women needed to be reached by telephone for 1 to become screened. CONCLUSIONS: The telephone outreach intervention delivered by MMCO staff increased CRC screening by 6% more than usual care among randomized women, and by 15.1% more than usual care among previously overdue women reached by the intervention. Our research-based intervention was successfully translated to the health plan arena, with variable effects in the participating MMCOs.
Authors: Charles E Basch; Randi L Wolf; Corey H Brouse; Celia Shmukler; Alfred Neugut; Lawrence T DeCarlo; Steven Shea Journal: Am J Public Health Date: 2006-10-31 Impact factor: 9.308
Authors: Carrie N Klabunde; Kathleen A Cronin; Nancy Breen; William R Waldron; Anita H Ambs; Marion R Nadel Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-06-08 Impact factor: 4.254
Authors: Allen J Dietrich; Jonathan N Tobin; Andrea Cassells; Christina M Robinson; Mary Ann Greene; Carol Hill Sox; Michael L Beach; Katherine N DuHamel; Richard G Younge Journal: Ann Intern Med Date: 2006-04-18 Impact factor: 25.391
Authors: Allen J Dietrich; Jonathan N Tobin; Andrea Cassells; Christina M Robinson; Meredith Reh; Karen A Romero; Ann Barry Flood; Michael L Beach Journal: Ann Fam Med Date: 2007 Jul-Aug Impact factor: 5.166
Authors: Elina S Kazarian; Fernando S Carreira; Neil W Toribara; Thomas D Denberg Journal: Clin Gastroenterol Hepatol Date: 2008-03-04 Impact factor: 11.382
Authors: Samir Gupta; Daniel A Sussman; Chyke A Doubeni; Daniel S Anderson; Lukejohn Day; Amar R Deshpande; B Joseph Elmunzer; Adeyinka O Laiyemo; Jeanette Mendez; Ma Somsouk; James Allison; Taft Bhuket; Zhuo Geng; Beverly B Green; Steven H Itzkowitz; Maria Elena Martinez Journal: J Natl Cancer Inst Date: 2014-03-28 Impact factor: 13.506
Authors: Gloria D Coronado; Jennifer L Schneider; Amanda Petrik; Jennifer Rivelli; Stephen Taplin; Beverly B Green Journal: Transl Behav Med Date: 2017-09 Impact factor: 3.046
Authors: Jennifer K Coury; Jennifer L Schneider; Beverly B Green; Laura-Mae Baldwin; Amanda F Petrik; Jennifer S Rivelli; Malaika R Schwartz; Gloria D Coronado Journal: Transl Behav Med Date: 2020-02-03 Impact factor: 3.046
Authors: Michael K Dougherty; Alison T Brenner; Seth D Crockett; Shivani Gupta; Stephanie B Wheeler; Manny Coker-Schwimmer; Laura Cubillos; Teri Malo; Daniel S Reuland Journal: JAMA Intern Med Date: 2018-12-01 Impact factor: 21.873
Authors: Seth A Berkowitz; Sanja Percac-Lima; Jeffrey M Ashburner; Yuchiao Chang; Adrian H Zai; Wei He; Richard W Grant; Steven J Atlas Journal: J Gen Intern Med Date: 2015-02-13 Impact factor: 5.128
Authors: Heather L M Dacus; Victoria L Wagner; Elisè A Collins; Jacqueline M Matson; Margaret Gates; Sonja Hoover; Florence K L Tangka; Teri Larkins; Sujha Subramanian Journal: Cancer Date: 2018-10-25 Impact factor: 6.860
Authors: Jonathan S Slater; Michael J Parks; Christina L Nelson; Kelly D Hughes Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-06-11 Impact factor: 4.254